HICKLIN DANIEL J has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 592690 shares of Werewolf Therapeutics, Inc. ($HOWL) on January 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | Werewolf Therapeutics, Inc. | $HOWL | HICKLIN DANIEL J | See Remarks | A | Stock Option (right to buy) | 592690 | $0.00 | 592,690.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Werewolf Therapeutics, Inc. | $HOWL | HICKLIN DANIEL J | See Remarks | A | Stock Option (right to buy) | 185652 | $0.00 | 185,652.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Werewolf Therapeutics, Inc. | $HOWL | HICKLIN DANIEL J | See Remarks | A | Stock Option (right to buy) | 435000 | $0.00 | 435,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Werewolf Therapeutics, Inc. | $HOWL | HICKLIN DANIEL J | See Remarks | A | Stock Option (right to buy) | 295500 | $0.00 | 295,500.0000 | 0 | 9999.99% | 0.00% |